Verona Pharma PLC ADR (VRNA) — Cash Flow Quality Index
Latest as of June 2025:
2.56x
Verona Pharma PLC ADR (VRNA) has a Cash Flow Quality Index of 2.56x as of June 2025. Operating cash flow of $30.56 Million exceeds net income of $11.92 Million, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Verona Pharma PLC ADR to assess how effectively this company generates cash.
Cash Flow Quality Index
2.56x
Operating CF / Net Income
Operating Cash Flow
$30.56 Million
USD
Net Income
$11.92 Million
USD
Data as of
Jun 2025
Most recent filing
Annual Cash Flow Quality Index for Verona Pharma PLC ADR (None–None)
Year-by-year earnings quality comparison for Verona Pharma PLC ADR. For live market cap and the full company financial profile, see VRNA market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.